Clinical Trial Update: Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of BCD-131 and Mircera for treating anemia in chronic kidney disease patients on dialysis; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• BCD-131
• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Biocad | Conditions: Anemia, Chronic Kidney Disease | Phase 3 | Status: RECRUITING